ID: ALA1808829

Max Phase: Preclinical

Molecular Formula: C49H48N4O11S

Molecular Weight: 901.01

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1O)CCN(C(=O)/C=C/c1ccccc1)[C@]21CS[C@@H]2c3c(OC(C)=O)c(C)c4c(c3[C@@H](COC1=O)N1[C@@H]2[C@H]2c3c(cc(C)c(OC)c3O)C[C@@H]([C@@H]1C#N)N2C)OCO4

Standard InChI:  InChI=1S/C49H48N4O11S/c1-24-16-29-17-31-32(20-50)53-33-21-61-48(58)49(30-19-35(59-5)34(55)18-28(30)14-15-52(49)36(56)13-12-27-10-8-7-9-11-27)22-65-47(41(53)40(51(31)4)37(29)42(57)43(24)60-6)39-38(33)46-45(62-23-63-46)25(2)44(39)64-26(3)54/h7-13,16,18-19,31-33,40-41,47,55,57H,14-15,17,21-23H2,1-6H3/b13-12+/t31-,32-,33+,40+,41+,47+,49+/m0/s1

Standard InChI Key:  MPIJWVINSIJMGK-UBUYTZHGSA-N

Associated Targets(Human)

QG-56 221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DU-145 51482 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 901.01Molecular Weight (Monoisotopic): 900.3040AlogP: 5.94#Rotatable Bonds: 5
Polar Surface Area: 180.56Molecular Species: NEUTRALHBA: 15HBD: 2
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.13CX Basic pKa: 5.37CX LogP: 6.28CX LogD: 6.26
Aromatic Rings: 4Heavy Atoms: 65QED Weighted: 0.14Np Likeness Score: 1.24

References

1. Saktrakulkla P, Toriumi S, Tsujimoto M, Patarapanich C, Suwanborirux K, Saito N..  (2011)  Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.,  19  (15): [PMID:21752654] [10.1016/j.bmc.2011.06.047]

Source